The Changping District People’s Government of Beijing Municipality has entered into a strategic cooperation agreement with Danaher Corporation (NYSE: DHR), a leading science and technology services provider based in the United States. The agreement encompasses the establishment of Danaher’s northern China headquarters in the district, along with the development of a synthetic biomanufacturing common technology platform. The financial specifics of the deal were not disclosed.
Danaher Corporation is known for its focus on life sciences, medical diagnostics, and biotechnology, offering comprehensive solutions across five key areas: medical diagnostics, antibody research and development, process development and preclinical research, process amplification and clinical research, and commercial production. The company plays a pivotal role in facilitating basic scientific research, driving the development of innovative drugs and new therapies, and hastening the translation of scientific findings into clinical applications. Danaher also supports medical institutions in enhancing their diagnostic and therapeutic capabilities, as well as in improving laboratory management standards.- Flcube.com
